The online brokerage reported a 35% drop in September monthly active users.

WSJ News Exclusive | Farallon Capital to Wage Proxy Battle at Biote…
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
The online brokerage reported a 35% drop in September monthly active users.
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Beijing is holding back its required green light for mergers that involve American companies as a technology war with Washington intensifies.
All those tech layoffs are starting to show up in employment statistics, but they still show little sign of spreading to other sectors.